Business

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research. The new release introduces BD Horizon™ Panel Maker, an AI-powered tool for automated panel design – one of the most critical steps across immunology and cancer research experiments designed to help ensure the quality

articleBecton, Dickinson And CompanyJanuary 23, 20263/company/becton-dickinson-and-company/news/bd-helps-scientists-advance-immunology-115000589
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

About this update from Becton, Dickinson And Company

[{"type":"text","content":"Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability of scientific results across research areas","length":180,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKLIN LAKES, N.J., Jan. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research. The new release introduces BD Horizon™ Panel Maker, an AI-powered tool for automated panel design – one of the most critical steps across immunology and cancer research experiments designed to help ensure the quality and usability of scientific results.","length":597,"tagName":"p"},{"type":"image","alt":"BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation","displaySize":"","headline":null,"caption":"BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/668dac2624242fc391117e5cc9734e6e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sQuILWwA.FmbJ5JSLUPhuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/668dac2624242fc391117e5cc9734e6e","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2867722/BD_Immunology.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"BD® Research Cloud version 7.0 provides scientists with a cloud-based ecosystem for flow cytometry that supports collaboration between team members, streamlines workflows, and manages laboratory operations, from instrument health to purchasing and managing reagents.","length":266,"tagName":"p"},{"type":"text","content":"The new BD Horizon™ Panel Maker tool leverages a novel, sophisticated AI algorithm to generate optimized panel recommendations within seconds. Researchers can create panels using custom experimental inputs or draw from curated databases of validated options. Poorly designed panels can lead to unusable, unreliable or irreproducible data, resulting in wasted time, sample...

More updates from Becton, Dickinson And Company

BD BiosciencesBecton, Dickinson and Companycancer researchResearchlife sciences researchpanel design